StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JAYSYNTH.BO$13.10+0.08%
Fair $13.10+0.0%

JAYSYNTH.BO

Jaysynth Orgochem Limited

Basic Materials / ChemicalsBSE

$13.10

+0.01 (+0.08%)

Fairly Valued+0.0%Fair Value $13.10Fund rank 27/100 · Data gapFallback financials|
SA 48/C
F-Score: 2/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $35.6M · quality 43.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · JAYSYNTH.BOLocal privado en este navegador · Jaysynth Orgochem Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.8B

P/E

12.0x

↓

EV/EBITDA

8.6x

↓

ROE

11.0%

↑

Gross Margin

31.7%

↑

Debt/Equity

0.31

↑
52-Week Range$13
$10$25

TradingView lightweight chart

JAYSYNTH.BO price, volumen y niveles de valoración

Último $13.10Periodo +127.8%
Fair value: $13.10

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+10.8%

FCF CAGR

—

FCF margin

-5.4%

FCF / Net income

-0.96x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.60B · net income $146.6M · FCF $-140.9M

2023-FY → 2026-FY

Gross margin

31.7%+6.6% pts

Operating margin

7.4%+6.4% pts

Net margin

5.6%+5.2% pts

FCF margin

-5.4%-12.9% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$2.60B$2.60B$2.28B$2.10B$1.91B
Net Income$146.6M$146.6M$156.2M$122.9M$7.7M
EBITDA$250.5M$250.5M$260.0M$203.3M$65.9M
EPS——1.160.910.06
Gross Margin31.7%31.7%33.8%27.5%25.2%
Operating Margin7.4%7.4%8.7%7.2%1.0%
Net Margin5.6%5.6%6.8%5.8%0.4%
Balance Sheet
Debt/Equity0.310.310.060.000.01
Current Ratio4.174.17———
Cash Flow
Free Cash Flow$-140.9M$-140.9M$36.0M$35.6M$142.5M
Returns
ROE11.0%11.0%12.7%11.1%0.8%
Valuation
P/E12.0212.0218.668.6376.00
EV/EBITDA8.658.6511.305.039.02
P/B1.321.322.370.960.65
Growth & Yield
Revenue Growth13.9%13.9%8.5%10.0%—
EPS Growth——27.5%1416.7%—
Dividend Yield0.4%0.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -38.3%

Total return

-38.3%

Start / end P/E

n/dx → n/dx

EPS bridge

1.16 → n/d

Residual

-38.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.4%
Residual / FX / buybacks / cross-term-38.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.